Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population

Exogenous estrogen is associated with reduced coronavirus disease (COVID) mortality in nonimmunosuppressed/immunocompromised (non-ISC) postmenopausal females. Here, we examined the association of estrogen or testosterone hormone replacement therapy (HRT) with COVID outcomes in solid organ transplant...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinson, Amanda J., Anzalone, Alfred, Schissel, Makayla, Dai, Ran, French, Evan T., Olex, Amy L., Mannon, Roslyn B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129906/
https://www.ncbi.nlm.nih.gov/pubmed/37105315
http://dx.doi.org/10.1016/j.ajt.2023.04.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129906/
https://www.ncbi.nlm.nih.gov/pubmed/37105315
http://dx.doi.org/10.1016/j.ajt.2023.04.020

Ejemplares similares